Keyphrases
Cannabis
100%
Brain Imaging
100%
Dopamine D2 Receptor (DRD2)
100%
Cannabis-induced Psychosis
100%
Ecstasy
60%
Healthy Controls
60%
Abusers
60%
Antipsychotics
40%
Dopaminergic Neurotransmission
40%
Treatment Facilities
40%
Cannabis Use
20%
Striatum
20%
Dopamine
20%
Single-photon Emission Computed Tomography (SPECT)
20%
Psychosis
20%
Psychosocial Support
20%
Psychosocial Treatment
20%
Drug Users
20%
Constant Rate Infusion
20%
Residual Effect
20%
Bolus Infusion
20%
Reward System
20%
Minimal Impact
20%
Putamen
20%
Caudate
20%
Caudate-putamen
20%
D2 Receptor
20%
Inpatient Treatment
20%
Clinical High Risk for Psychosis (CHR-P)
20%
123I
20%
Medication Support
20%
Psychotic Episode
20%
Iodobenzamide
20%
Medicine and Dentistry
Cannabis
100%
Brain Imaging
100%
Cannabis-Induced Psychosis
100%
Dopamine Receptor D2
100%
Midomafetamine
60%
Putamen
40%
Synaptic Transmission
40%
Antipsychotic
40%
Cannabis Use
20%
Computer Assisted Tomography
20%
Infusion
20%
Receptor
20%
Single-Photon Emission Computed Tomography
20%
Psychosocial Care
20%
Effects of Cannabis
20%
Striatum
20%
Iodine 123
20%
Diseases
20%
Neuroscience
Cannabis
100%
Brain Imaging
100%
Dopamine Receptor D2
100%
Cannabis-Induced Psychosis
100%
MDMA
50%
Synaptic Transmission
33%
Putamen
33%
Antipsychotic
33%
Computed Tomography
16%
Striatum
16%
Single-Photon Emission Computed Tomography
16%
Iodine-123
16%
Iodobenzamide
16%
Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabis
100%
Dopamine Receptor D2
100%
Cannabis-Induced Psychosis
100%
MDMA
50%
Antipsychotic
33%
Receptor
16%
Iodobenzamide
16%
Iodine-123
16%
Diseases
16%